According to the new market research report ” Orthobiologics Market by Product (Viscosupplementation, Synthetic Orthobiologics, DBM, BMP, PRP, BMAC, Allograft), Application (Fracture Recovery, Osteoarthritis, Spinal Fusion, Soft Tissue), End User (Hospitals, ASCs, Academia) – Global Forecast to 2022″, published by MarketsandMarkets™, The global orthobiologics market is expected to reach USD 6.06 Billion by 2022 from USD 4.44 Billion in 2016 at a CAGR of 5.4% during the forecast period.
Don’t miss out on business opportunities in Orthobiologics Market
Browse and in-depth TOC on “Orthobiologics Market”
60 – Tables
38 – Figures
159 – Pages
Orthobiologics Market : Years considered for the study are as follows
- Base Year: 2016
- Forecast Period: 2017–2022
To know about the assumptions considered for the study, download the pdf brochure
This research study involves the extensive usage of secondary sources, directories, and databases (such as Hoover’s, Bloomberg Business, Factiva, and Avention), in order to identify and collect information useful for this technical, market-oriented, and financial study of the market. In-depth interviews were conducted with various primary respondents, including subject-matter experts (SMEs), C-level executives of key market players, and industry consultants to obtain and verify qualitative and quantitative information and to assess market prospects.
Get Free 10%
customization:
https://www.marketsandmarkets.com/requestCustomizationNew.asp?id=162747970
Company Information
The global orthobiologics market is projected to reach USD 6.06 Billion by 2022 from USD 4.66 Billion in 2017, at a CAGR of 5.4% during the forecast period. Factors such as rising burden of orthopedic injuries; increasing incidence of sports injuries and road accidents; increasing incidence of spinal fusion surgeries; risk factors associated with increasing aging population, obesity rate, & high incidence of musculoskeletal disorders; and growing patient preference for minimally invasive procedures are driving the market.
To speak to our analyst for a discussion on the above findings, click Speak to Analyst
